| Confident Counseling Services Of Newburgh | |
|
333 State St Ste B Newburgh IN 47630-1270 | |
| (812) 598-3959 | |
| (812) 993-1164 |
| Full Name | Confident Counseling Services Of Newburgh |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 333 State St Ste B, Newburgh, Indiana |
| Authorized Official Name and Position | Jean Zelenko (OWNER/ PROVIDER) |
| Authorized Official Contact | 8125983959 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Confident Counseling Services Of Newburgh 333 State St Ste B Newburgh IN 47630-1270 Ph: (812) 598-3959 | Confident Counseling Services Of Newburgh 333 State St Ste B Newburgh IN 47630-1270 Ph: (812) 598-3959 |
| NPI Number | 1346697828 |
|---|---|
| Provider Enumeration Date | 05/16/2016 |
| Last Update Date | 03/17/2022 |
| Certification Date | 03/17/2022 |
| Medicare PECOS PAC ID | 5395037824 |
|---|---|
| Medicare Enrollment ID | O20160701001148 |
News Archive
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346697828 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 34006270A (Indiana) | Primary |
| Provider Name | Jean Zelenko |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1154601656 PECOS PAC ID: 7416249941 Enrollment ID: I20160701001430 |
News Archive
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
› Verified 7 days ago
| Provider Name | Tiffany D Beck |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1982107017 PECOS PAC ID: 7416203310 Enrollment ID: I20180709000249 |
News Archive
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
› Verified 7 days ago
| Provider Name | Leslie M Payton |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1669967444 PECOS PAC ID: 3072860915 Enrollment ID: I20180723003317 |
News Archive
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
› Verified 7 days ago
| Provider Name | Kalyn Goodwin-shelton |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1649992496 PECOS PAC ID: 8426424912 Enrollment ID: I20221025002420 |
News Archive
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
› Verified 7 days ago
News Archive
Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
In his first U.N. General Assembly address, President Obama on Wednesday "called for 'a new era of engagement' ... with the world, pledging to work together with other countries while defending the interests of the United States," Reuters reports (9/23).
› Verified 7 days ago
Brainpower Neurodevelopmental Center, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5155 Rosebud Ln, Newburgh, IN 47630 Phone: 812-773-8321 Fax: 812-961-6546 | |
The Women's Hospital Provider Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4199 Gateway Blvd, Newburgh, IN 47630 Phone: 812-842-4200 Fax: 812-842-4227 | |
Moxie Professional Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 333 State St Ste B, Newburgh, IN 47630 Phone: 812-777-5230 Fax: 812-315-0222 | |
Deaconess Pain Clinic Mob5 Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4133 Gateway Blvd Ste 290, Newburgh, IN 47630 Phone: 812-450-7246 Fax: 812-450-4855 | |
Vivian Ireton Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5048 S Plaza Dr, Ste B, Newburgh, IN 47630 Phone: 812-449-9355 Fax: 812-607-9316 | |
Full Bloom Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 8199 Robin Hill Rd Ste C, Newburgh, IN 47630 Phone: 812-215-5584 Fax: 812-215-5884 | |
Deaconess Clinic I Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4015 Gateway Blvd, Newburgh, IN 47630 Phone: 812-858-9400 Fax: 812-858-9571 |